(a) scientific, medical, and ethical standards;
(b) standards for all medical, socioeconomic, and financial aspects of
clinical trials and therapy delivery to patients, including, but not
limited to standards for safe and ethical procedures for: obtaining
materials and cells for research; clinical efforts for the appropriate
treatment of human subjects in medical research; and ensuring compliance
with patient privacy laws;
(c) oversight of funded research to ensure compliance with the
standards described in paragraphs (a) and (b) of this subdivision; and
(d) relevant ethical and regulatory issues.
3. With the exception of the ex officio member, the ethics committee
shall be divided into three classes. Of the three classes, the first
class appointed shall include three of the governor's appointees, one
appointee nominated by the temporary president of the senate, and one
appointee nominated by the speaker of the assembly; and shall serve for
a term ending one year from the effective date of this title. The second
class shall include two of the governor's appointees, one appointee
nominated by the minority leader of the senate, and one appointee
nominated by the minority leader of the assembly; and shall serve for a
term ending two years from the effective date of this title. The third
class shall include the final governor's appointee, one appointee
nominated by the temporary president of the senate, and one appointee
nominated by the speaker of the assembly; and shall serve for a term
ending three years from the effective date of this title. Subsequently,
each member appointed shall serve a term of three years and no more than
two terms of three years each. A vacancy in the membership of the board
shall be filled for the unexpired portion of the term in the same manner
as the original appointment.
* NB Repealed December 31, 2025